Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Depreciation & Amortization - Total (2014 - 2018)

Mesoblast's (MEOBF) quarterly Depreciation & Amortization - Total came in at -$160000.0 in Q3 2018, up 40.07% year-over-year from -$114224.6 in Q3 2017, and up 40.07% quarter-over-quarter from -$267000.0 in Q3 2017.

Analysis

Mesoblast (MEOBF) Depreciation & Amortization - Total (2014 - 2018) Analysis & Trends

Mesoblast has disclosed Depreciation & Amortization - Total across 5 years of filings, most recently posting -$160000.0 for Q3 2018.

  • In Q3 2018, Depreciation & Amortization - Total rose 40.07% year-over-year to -$160000.0; the TTM figure through Sep 2018 stood at -$1.2 million (up 15.83% YoY), while the FY2026 annual figure was -$481000.0, down 58.75% from the prior year.
  • Depreciation & Amortization - Total came in at -$160000.0 for Q3 2018 at Mesoblast, up from -$267000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of -$160000.0 in Q3 2018 to a low of -$410000.0 in Q3 2016.
  • Average Depreciation & Amortization - Total over 5 years is -$327600.0, with a median of -$394000.0 recorded in 2014.
  • Year-over-year, Depreciation & Amortization - Total slipped 3.3% in 2015 and soared 40.07% in 2018.
  • Over 5 years, Depreciation & Amortization - Total stood at -$394000.0 in 2014, then slipped by 3.3% to -$407000.0 in 2015, then fell by 0.74% to -$410000.0 in 2016, then jumped by 34.88% to -$267000.0 in 2017, then soared by 40.07% to -$160000.0 in 2018.
  • Per Business Quant data, the three most recent Depreciation & Amortization - Total figures were -$160000.0 in Q3 2018, -$267000.0 in Q3 2017, and -$410000.0 in Q3 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Krystal Biotech 10.13 Bn 9.29 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.23 Bn 5.23 Bn - -
3 Iovance Biotherapeutics 3.82 Bn 3.52 Bn 55.72 Mn -
4 Legend Biotech 3.68 Bn 2.72 Bn 251.50 Mn -
5 uniQure 3.08 Bn 3.08 Bn 5.49 Mn -
6 Beam Therapeutics 2.67 Bn 2.67 Bn - -
7 Precigen 2.43 Bn 2.43 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.33 Bn 1.54 Bn 251.87 Mn -
9 Vericel 2.00 Bn 1.84 Bn 56.40 Mn -
10 Mesoblast 246.02 Mn 143.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -160,000.00
Sep 30, 2017 -267,000.00
Sep 30, 2016 -410,000.00
Sep 30, 2015 -407,000.00
Sep 30, 2014 -394,000.00